Insel Gruppe Ag, University Hospital Bern
Clinical trials sponsored by Insel Gruppe Ag, University Hospital Bern, explained in plain language.
-
Weight-Loss drug may also help curb drinking, new study suggests
Disease control Not yet recruitingThis study is testing if a medication called semaglutide, which is used for weight loss and diabetes, can also help people with obesity and fatty liver disease drink less alcohol or stop drinking altogether. Researchers will compare two groups: one group will receive the medicati…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Brain mapping tech aims to sharpen cancer radiation, protect movement
Disease control Not yet recruitingThis study is testing whether a special brain mapping technique can help doctors plan radiation therapy more precisely for patients who have had a brain tumor near the area that controls movement removed. The goal is to focus the radiation dose on any remaining cancer cells while…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Heart procedure aims to zap dangerous radiation
Disease control Not yet recruitingThis study is testing if using a special ultrasound probe inside the heart can reduce radiation exposure for patients during a procedure to fix irregular heartbeats. 70 adults needing this treatment will be randomly assigned to either get the new ultrasound-guided method or the s…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug aims to protect hearts during surgery
Disease control Not yet recruitingThis study is testing if carefully controlling heart rate during and after major surgery can reduce heart injury in at-risk patients. It will use a fast-acting heart rate medication called landiolol in 114 adults over 45 with heart risk factors. The main goal is to see if this ap…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Balloon in the aorta: a new hope for saving lives during cardiac arrest?
Disease control Not yet recruitingThis study is testing if adding a special balloon device to standard CPR helps more people survive an in-hospital cardiac arrest. The balloon is placed in the main artery to temporarily redirect blood flow to the heart and brain. Researchers will compare survival rates between pa…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Blood test could replace frequent biopsies for prostate cancer monitoring
Diagnosis Not yet recruitingThis study is testing whether a blood test called Stockholm3 can accurately detect when prostate cancer becomes more aggressive in men who are being monitored instead of immediately treated. Researchers want to see if this test can help doctors safely follow patients with fewer i…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC
-
Scientists probe: is Lab-Made nicotine different?
Knowledge-focused Not yet recruitingThis study aims to understand how the body processes and reacts to synthetic nicotine and nicotine-like chemicals from e-cigarettes, compared to regular tobacco nicotine. It will involve 24 adults who currently use e-cigarettes. Participants will use different e-cigarette product…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC